Diabetes Drugs
Farxiga and Xigduo Diabetes Drug Makers Face MDL in New York
The Judicial Panel on Multidistrict Litigation established a multidistrict litigation (MDL) in New York to hear claims of diabetic ketoacidosis and kidney damage allegedly caused by the Farxiga and Xigduo diabetes drugs. Farxiga and its sister drug Xigduo XR are manufactured by Bristol-Myers Squibb Co., AstraZeneca Pharmaceuticals … [Read more...] about Farxiga and Xigduo Diabetes Drug Makers Face MDL in New York
Emergency Department Visits for Adverse Drug Events
Research of Adverse Drug ED Visits. A new study has found that one in 250 individuals will experience an adverse drug reaction and require treatment in an emergency department (ED). Adverse drug event prevention was a target for the Patient Protection and Affordable Care Act of 2010. The result was new programs to further the … [Read more...] about Emergency Department Visits for Adverse Drug Events
DPP-4 Inhibitor Type 2 Diabetes Drugs Associated with Serious Side Effects
DPP-4 Inhibitor Serious Side Effects. Dipeptidyl peptidase 4 inhibitors (DPP-4 inhibitors), a class of oral diabetes medications that includes Januvia, Onglyza, Trajenta, and Nesina, treat Type 2 diabetes by blocking DPP-4. Oral DPP-4 inhibitors work by increasing incretin levels in the pancreas which, in turn, inhibits the … [Read more...] about DPP-4 Inhibitor Type 2 Diabetes Drugs Associated with Serious Side Effects
FDA Infants taking Proglycem Warning
The Risk Of Proglycem to Children. Proglycem, a drug used to treat low blood sugar, has been associated with reports of pulmonary hypertension in infants and newborns taking the medication, the U.S. Food and Drug Administration (FDA) warned. Pulmonary hypertension is a serious lung condition where there is high blood pressure in … [Read more...] about FDA Infants taking Proglycem Warning
FDA Warning: Newer Type 2 Diabetes Drugs May Cause Ketoacidosis
some of the newer Type 2 diabetes medicines may lead to ketoacidosis FDA Warns Patients About The Diabetes Drugs Ketoacidosis Risk. The Food and Drug Administration (FDA) is warning that some of the newer Type 2 diabetes medicines canagliflozin (Invokana), dapagliflozin (Farxiga), and empagliflozin (Jardiance) may lead to … [Read more...] about FDA Warning: Newer Type 2 Diabetes Drugs May Cause Ketoacidosis
Statin Risk of Type 2 Diabetes
STATIN MEDICATIONS INCREASE RISK OF TYPE 2 DIABETES. A new study published in Diabetologia shows that use of statin medications, which is often used to lower cholesterol, can significantly increase the risk of developing type 2 diabetes. Medical News Today reports that the association between statin therapy and type 2 … [Read more...] about Statin Risk of Type 2 Diabetes
Link Between Januvia and Pancreatic Cancer
Potential Link Between Januvia and Pancreatic Cancer. Federal health officials are set to launch an investigation into a possible link between the type 2 diabetes drug Januvia (sitagliptin) and a risk of pancreatic cancer. According to a New York Times report, the U.S. Food and Drug Administration (FDA) is acting on the research … [Read more...] about Link Between Januvia and Pancreatic Cancer
FDA identifies stumbling blocks for new diabetes drug
Rash of Diabetes Drug Side Effects. The Food and Drug Administration issued a statement this week indicating that a clinical trial of a new type 2 diabetes drug has suffered some setbacks as there have been a rash of dangerous side effects reported among its participants. According to a Reuters report, the FDA published a report … [Read more...] about FDA identifies stumbling blocks for new diabetes drug
Sulfonylureas Risk Of Heart Problems
Sulfonylureas Higher Risk Of Heart Problems. Sulfonylureas, a claid ass of drugs long used in the treatment of type 2 diabetes, have been linked with an increased risk of death and cardiac failure over newer treatments, according to research, writes the Palm Beach Post. The study—which agreed with current American … [Read more...] about Sulfonylureas Risk Of Heart Problems
Lantus Studies Cancer Worries
Lantus Studies Raise Cancer. Lantus, the blockbuster diabetes drug made by Sanofi-Aventis, may increase the risk of cancer in some patients. The possible link, seen in some new European Lantus studies, prompted the European Association for the Study of Diabetes to call for more studies on the drug. Lantus is an insulin analogue - … [Read more...] about Lantus Studies Cancer Worries
Statins Risky for MS Patients
Statins Risky for MS Patients. Some statins—drugs that lower blood cholesterol levels—have been linked to various adverse events. Now, an emerging study has found that the medications might be negatively affecting patients with Multiple Sclerosis (MS), reports Science Daily, especially in those patients taking high daily doses of … [Read more...] about Statins Risky for MS Patients
Diabetes Drugs Need Tougher Testing for Heart Risk
Tougher Testing Requirements For Diabetes Drugs. Last week, a Food & Drug Administration (FDA) advisory panel voted to back tougher testing requirements for diabetes drugs. In a 14-2 vote, which came late last Wednesday at the end of 2-day meeting, the outside experts recommended that diabetes drugs undergo more … [Read more...] about Diabetes Drugs Need Tougher Testing for Heart Risk
Michigan Rezulin Lawsuit Goes Ahead
Michigan Rezulin Lawsuit. A Rezulin lawsuit will proceed in Michigan, after the US Supreme Court deadlocked over a case regarding patients' rights to sue over injuries they receive from drugs that are approved by the Food & Drug Administration (FDA). Pfizer, Inc., the maker of Rezulin, was trying to convince the Court to … [Read more...] about Michigan Rezulin Lawsuit Goes Ahead
Warfarin, Insulin, Digoxin Medications to Send Seniors to the ER
Warfarin, Insulin, Digoxin Send More Senior Citizens To ER. Medications to Send Seniors to the ER, Warfarin, insulin and digoxin drug side effects send more senior citizens to the emergency room than any other medications, a new report says. And while each of these drugs treats a different condition, the Centers for Disease … [Read more...] about Warfarin, Insulin, Digoxin Medications to Send Seniors to the ER
FDA Antibiotic Tequin Ban
Ban Antibiotic Tequin. Public Citizen has petitioned the U.S. Food and Drug Administration (FDA) to ban the antibiotic Tequin because it is linked to blood sugar abnormalities and has caused deaths and hospitalizations. The drug, made by Bristol-Myers Squibb and approved for use in the United States in December 1999, has been … [Read more...] about FDA Antibiotic Tequin Ban
Muraglitazar Potential Blockbuster Diabetes Drug
Muraglitazar Potentially Deadly Results. Noted experts fear Vioxx-like scenario is about to be repeated with potentially deadly results for those who would take the drug that is about to be approved for sale. An eagerly awaited diabetes drug, which is nearing final approval by the FDA, significantly increases the risk of … [Read more...] about Muraglitazar Potential Blockbuster Diabetes Drug
Proposed Diabetes Drug Serious Health Risks
Researchers at The Cleveland Clinic recently completed an analysis of clinical trials on muraglitazar (Pargluva), a new diabetes drug, finding that it doubles the risk of death, heart attack, and stroke. The results appeared in Thursday’s Journal of the American Medical Association (JAMA). Because of the study’s potential impact … [Read more...] about Proposed Diabetes Drug Serious Health Risks
Novo Nordisk Shares May Fall After Warning on Diabetes Drug
Novo Nordisk Diabetes Drug Side Effect. Shares of Novo Nordisk A/S, the world's largest maker of diabetes drugs, may fall after the Danish company and Canadian regulators warned that Novo's GlucoNorm treatment may have a potentially fatal side effect when taken with another medicine. The combination of Novo's GlucoNorm … [Read more...] about Novo Nordisk Shares May Fall After Warning on Diabetes Drug
Warnings Added to Diabetes Drugs
GlaxoSmithKline and Eli Lilly & Company Diabetes Drugs May Cause Liver Damage. GlaxoSmithKline and Eli Lilly & Company have added warnings about heart and liver risks to the labels of their diabetes drugs, which are similar to a medication that was withdrawn from the market in 2000 because of links to fatal liver damage. The Food … [Read more...] about Warnings Added to Diabetes Drugs
Diabetes Drugs Heart Failure Risk
Diabetes Drugs May Cause Heart Failure. Diabetics who use oral drugs to control their disease face a 50 percent increase in the risk for heart failure compared to those who do not take use the drugs, researchers said Tuesday at a American College of Cardiology conference. The drugs belong to a class of drugs called glitazones and … [Read more...] about Diabetes Drugs Heart Failure Risk
Pfizer Settles Diabetes Drug Lawsuit
Pfizer Diabetes Drug Lawsuit. A woman who said her liver was destroyed by Pfizer Inc.'s recalled diabetes drug, Rezulin, still faces the prospect of a transplant. But her attorneys say a settlement reached with the drug giant hours after it lost a huge jury verdict will bring her justice. The amount of the settlement was not … [Read more...] about Pfizer Settles Diabetes Drug Lawsuit
